RT @doctorRBC: Biosimilar to biosimilar effective in treatment of RA/PsA/AxSpA. Large study looking at infliximab biosi
Tweet Content
Biosimilar to biosimilar effective in treatment of RA/PsA/AxSpA.
Large study looking at infliximab biosimilar switching - resulted in high retention rates and virtually no change in disease activity.
@RheumNow #ACR22 Abs#1112 https://t.co/uNRXLewo4M
Show on Archive Page
On
Display in Search Results
On
PDQ
Off